EIM Group
http://www.eimgroup.com/jahia/page2.htmlEIM Group is a fund of fund that focuses on identifying, screening, and analyzing the best fund managers in different markets and investment styles.
View Older Stories View More Recent Stories
-
Neurosense Therapeutics (NRSN) Granted European Patent Related to Parkinson's and AD
-
Skel fjárfestingafélag hf.: Transaction of party closely associated with a board member
-
Eimskip: Results for Q3 2022
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
CORRECTING and REPLACING Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
UNITY Biotechnology (UBX) Reports Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325
-
Hagar hf.: Reglubundin tilkynning um kaup Haga hf. á eigin bréfum í samræmi við endurkaupaáætlun
-
Docufree Acquires Document Intelligence Solution Provider DealerDOCX
-
Eimskip: Information regarding Q3 results
-
Eimskip: Transaction in relation to a share buy-back program – repurchase is completed
-
Alogent Extends its Leadership in the Enterprise Content & Information Management Market for Financial Institutions with the Acquisition of AccuSystems
-
Eimskip: Transaction in relation to a share buy-back program
-
Chicago Behavior Center Utilizes Innovative Virtual Reality to Treat Obsessive-Compulsive Disorder and Anxiety Disorders
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Eimskip: Transaction in relation to a share buy-back program
-
VÍS: Tilkynning um framkvæmd endurkaupaáætlunar
-
Eimskip: Transaction in relation to a share buy-back program
-
Eimskip: Major shareholder announcement from LSR
-
Eimskip: Transaction in relation to a share buy-back program
-
Frequency Electronics (FEIM) Reports Q2 Loss of $0.33
-
Eimskip: Transaction in relation to a share buy-back program
-
Eimskip: Transaction in relation to a share buy-back program
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Landos Biopharma (LABP) Granted U.S. Patent for Alzheimer's and Parkinson Treatment
-
Sjóvá: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
-
Eimskip: Transaction in relation to a share buy-back program
-
Eimskip: Share buy-back program initiated
-
Eimskip: Results for Q2 2022
-
Accenture (ACN) Acquires YSC Consulting
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
ClearInfo and Carahsoft Partner to Deliver the Data Assembly Service Platform to the Federal Government
-
CubyFun launches JOYO smart board game on Kickstarter following $1.5M investment round
-
CubyFun launches JOYO smart board game on Kickstarter following $1.5M investment round
-
Eimskip: Information regarding Q2 results
-
Eimskip: Transaction in relation to a share buy-back program – repurchase is completed
-
Eimskip: Transaction in relation to a share buy-back program
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
AC Immune SA (ACIU) received a Notice of Allowance for its US patent - Patent Grant
-
Transforming Education for the Real-world: No subjects, no classrooms, no exams
-
Eimskip: Transaction in relation to a share buy-back program
-
The Port of Seattle selects Locus Technologies for its Environmental Software
-
Breytingar á stórnendateymi PLAY samhliða auknum umsvifum
-
Eimskip: Transaction in relation to a share buy-back program
-
Collision Conference 2022 Must See - Wright Brothers of Data
-
Eimskip: Transaction in relation to a share buy-back program
-
Eimskip: Transaction in relation to a share buy-back program
-
Sjóvá: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
-
Confluent Health Expands Leadership Team with New Partner CEO
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Eimskip: Share buy-back program initiated

